Novostia
A clinical stage company developing a breakthrough artificial heart valve
Novostia has raised €2.5M across 1 funding round, most recently a Series B round in May 2023. Based in Lausanne, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Lausanne, Switzerlandwww.novostia.com ↗
Total raised
€2.5M
€2,500,000
Funding rounds
1
Investors
0
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearNovostia — funding by year — interactive chart.
Data table
| Novostia — funding by year | |
|---|---|
| 2023 | €2.5M |
Signals
Medium confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-03 | Series B | €2.5M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData